PARP1 and Familial prostate cancer: In a previous report, cell viability curves were compared between temozolomide, camptothecin, and cisplatin in DT40 cells (chicken lymphoma cell line) and DU145 cells (prostate cancer cell line), and PARP inhibitor just added its own cytotoxicity [16].